Literature DB >> 2481343

Interferon treatment of viral hepatitis in immunocompromised patients.

G L Davis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481343     DOI： 10.1055/s-2008-1040522

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  6 in total

1.  Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

2.  Interferon-associated left ventricular dysfunction in a liver transplant recipient.

Authors:  R Mateo; S Jethmalani; D C Angus; J Gorcsan; B Uretsky; J Fung
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

3.  Antiviral L-nucleosides specific for hepatitis B virus infection.

Authors:  M L Bryant; E G Bridges; L Placidi; A Faraj; A G Loi; C Pierra; D Dukhan; G Gosselin; J L Imbach; B Hernandez; A Juodawlkis; B Tennant; B Korba; P Cote; P Marion; E Cretton-Scott; R F Schinazi; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

4.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

5.  Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.

Authors:  T Wölfel; P Schirmacher; J Schlaak; P Knolle; H P Dienes; W Dippold; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1994-12

6.  HIV and Hepatitis Virus Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.663
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.